Please refrain from including sensitive medical information
Jean-Philip Deslauriers Clinical Professor at the University of Sherbrooke Rheumatologist Bathurst, New Brunswick
Shahid MA, Balal RM, Khan N, Zotarelli L, Liu GD, Sarkhosh A, Fernndez-Zapata JC, Nicols JJM, Garcia-Sanchez F
The four-pathway approach activates mechanisms that single or dual agonists cannot reach, potentially overcoming resistance that develops with prolonged use of less comprehensive compounds
Rosa, L., Cutone, A., Lepanto, M
Once successfully transported into the brain tissue, the newly synthesized glutathione helps clear neurotoxic metabolic byproducts and significantly reduces microglial activation, which is the primary driver of neuroinflammation